Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T15:02:08.984Z.
Calculation as of: 2026-10-06T15:02:08.984Z.
Quote observation: 2026-10-06T15:00:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 07daf27a5d98c2e6040b1a84eec716383e035dd1d7ed5c9da608703ba97b77ea
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$31.36M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.77M
PE Ratio
30.91
TTM Avg
37.13
3Y Avg
14.27
5Y Avg
11.10
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CervoMed Inc. (CRVO) | $30.18M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.95M | N/A | 0.40 | 0.40 | 0.40 |
| Context Therapeutics Inc. (CNTX)vs › | $31.28M | N/A | N/A | N/A | N/A |
| MDxHealth S.A. (MDXH)vs › | $31.10M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $29.23M | N/A | 414.61 | 414.61 | 195.55 |
| BeyondSpring Inc. (BYSI)vs › | $31.26M | N/A | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $31.03M | N/A | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 30.91 | 37.13 | 14.27 | 11.10 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.79M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.26
Forward EPS (Est.)
$-2.15
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2014-06-30 | 769.44 |
| 2014-06-27 | 736.30 |
| 2014-06-26 | 743.67 |
| 2014-06-25 | 717.90 |
| 2014-06-24 | 745.51 |
| 2014-06-23 | 717.90 |
| 2014-06-20 | 771.28 |
| 2014-06-19 | 736.30 |
| 2014-06-18 | 782.32 |
| 2014-06-17 | 727.10 |
| 2014-06-16 | 773.12 |
| 2014-06-13 | 754.71 |
| 2014-06-12 | 754.71 |
| 2014-06-11 | 754.71 |
| 2014-06-10 | 745.51 |
| 2014-06-09 | 736.30 |
| 2014-06-06 | 773.12 |
| 2014-06-05 | 773.12 |
| 2014-06-04 | 773.12 |
| 2014-06-03 | 763.92 |
| 2014-06-02 | 754.71 |
| 2014-05-30 | 736.30 |
| 2014-05-29 | 791.53 |
| 2014-05-28 | 791.53 |
| 2014-05-27 | 736.30 |
| 2014-05-23 | 828.34 |
| 2014-05-22 | 1010.58 |
| 2014-05-21 | 800.73 |
| 2014-05-20 | 782.32 |
| 2014-05-19 | 920.38 |
| 2014-05-16 | 920.38 |
| 2014-05-15 | 920.38 |
| 2014-05-14 | 994.01 |
| 2014-05-13 | 920.38 |
| 2014-05-12 | 920.38 |
| 2014-05-09 | 920.38 |
| 2014-05-08 | 795.21 |
| 2014-05-07 | 844.91 |
| 2014-05-06 | 920.38 |
| 2014-05-05 | 920.38 |
| 2014-05-02 | 920.38 |
| 2014-05-01 | 920.38 |
| 2014-04-30 | 865.16 |
| 2014-04-29 | 977.44 |
| 2014-04-28 | 1012.42 |
| 2014-04-25 | 966.40 |
| 2014-04-24 | 883.57 |
| 2014-04-23 | 883.57 |
| 2014-04-22 | 1104.46 |
| 2014-04-21 | 1104.46 |
| 2014-04-17 | 1104.46 |
| 2014-04-16 | 938.79 |
| 2014-04-15 | 938.79 |
| 2014-04-14 | 920.38 |
| 2014-04-11 | 920.38 |
| 2014-04-10 | 920.38 |
| 2014-04-09 | 1012.42 |
| 2014-04-08 | 1086.05 |
| 2014-04-07 | 1141.27 |
| 2014-04-04 | 1086.05 |
| 2014-04-03 | 1076.85 |
| 2014-04-02 | 1076.85 |
| 2014-04-01 | 1104.46 |
